Cargando…
SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome
PURPOSE: Prader–Willi syndrome (PWS) is a neurodevelopmental disorder with hypothalamic dysfunction due to deficiency of imprinted genes located on the 15q11-q13 chromosome. Among them, the SNORD116 gene appears critical for the expression of the PWS phenotype. We aimed to clarify the role of SNORD1...
Autores principales: | Eddiry, Sanaa, Diene, Gwenaelle, Molinas, Catherine, Salles, Juliette, Auriol, Françoise Conte, Gennero, Isabelle, Bieth, Eric, Skryabin, Boris V., Rozhdestvensky, Timofey S., Burnett, Lisa C., Leibel, Rudolph L., Tauber, Maithé, Salles, Jean Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460435/ https://www.ncbi.nlm.nih.gov/pubmed/34040195 http://dx.doi.org/10.1038/s41436-021-01185-y |
Ejemplares similares
-
Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome
por: Bar, Céline, et al.
Publicado: (2017) -
Is ghrelin a biomarker of early-onset scoliosis in children with Prader–Willi syndrome?
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2021) -
French database of children and adolescents with Prader-Willi syndrome
por: Molinas, Catherine, et al.
Publicado: (2008) -
Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome
por: Polex-Wolf, Joseph, et al.
Publicado: (2018) -
Equivocal expression of emotions in children with Prader-Willi syndrome: what are the consequences for emotional abilities and social adjustment?
por: Famelart, Nawelle, et al.
Publicado: (2020)